Edwards Lifesciences Cash Flow from Investing Activities 2010-2025 | EW
Edwards Lifesciences cash flow from investing activities for the twelve months ending March 31, 2025 was $5.476B, a 1071.77% increase year-over-year.
- Edwards Lifesciences annual cash flow from investing activities for 2024 was $2.313B, a 1230.78% increase from 2023.
- Edwards Lifesciences annual cash flow from investing activities for 2023 was $0.174B, a 31.11% decline from 2022.
- Edwards Lifesciences annual cash flow from investing activities for 2022 was $0.252B, a 114.65% decline from 2021.